Citation Impact
Citing Papers
A Novel Germline Variant in CSF3R Reduces N-Glycosylation and Exerts Potent Oncogenic Effects in Leukemia
2018 StandoutNobel
TP53 Mutations in Low-Risk Myelodysplastic Syndromes With del(5q) Predict Disease Progression
2011
A mechanosensory complex that mediates the endothelial cell response to fluid shear stress
2005 StandoutNature
Hypoxia — a key regulatory factor in tumour growth
2002 Standout
Oxygen-regulated transcription factors and their role in pulmonary disease
2000 StandoutNobel
Receptor-specific Ubiquitination of β-Arrestin Directs Assembly and Targeting of Seven-transmembrane Receptor Signalosomes
2005 StandoutNobel
LPS induction of gene expression in human monocytes
2001 Standout
Role of JNK/ATF-2 pathway in inhibition of thrombospondin-1 (TSP-1) expression and apoptosis mediated by doxorubicin and camptothecin in FTC-133 cells
2011 StandoutNobel
Molecular mechanisms underlying chemopreventive activities of anti-inflammatory phytochemicals: down-regulation of COX-2 and iNOS through suppression of NF-κB activation
2001 Standout
Body Fatness and Cancer — Viewpoint of the IARC Working Group
2016 Standout
Are myelodysplastic syndromes “cancer”?
2006
Effects of Flavonoids and other Polyphenols on Inflammation
2011 Standout
Molecular dissection of reactive astrogliosis and glial scar formation
2009 Standout
Pathways of Egr-1-Mediated Gene Transcription in Vascular Biology
1999
Lipopolysaccharide Induction of the Tumor Necrosis Factor-α Promoter in Human Monocytic Cells
1997
Intracellular Signaling Pathways Regulating Pluripotency of Embryonic Stem Cells
2006 StandoutNobel
Genomic instability in myeloid malignancies: Increased reactive oxygen species (ROS), DNA double strand breaks (DSBs) and error-prone repair
2008
The Protective Effects of Estrogen on the Cardiovascular System
1999 Standout
Hypoxia-associated Induction of Early Growth Response-1 Gene Expression
1999
Delivery and Expression of Fluid Shear Stress-Inducible Promoters to the Vessel Wall: Applications for Cardiovascular Gene Therapy
1999
Transcriptional regulation by calcium, calcineurin, and NFAT
2003 Standout
ASXL1 mutation is associated with poor prognosis and acute transformation in chronic myelomonocytic leukaemia
2010
Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistance
2006 Standout
What a difference a hydroxyl makes: mutant IDH, (R)-2-hydroxyglutarate, and cancer
2013 StandoutNobel
Sp1 is an essential transcription factor for LPS-induced tissue factor expression in THP-1 monocytic cells, and nobiletin represses the expression through inhibition of NF-κB, AP-1, and Sp1 activation
2008
Shear stress induction of the tissue factor gene.
1997
Reactive oxygen species (ROS) as pleiotropic physiological signalling agents
2020 Standout
Egr-1 Regulates Expression of the Glial Scar Component Phosphacan in Astrocytes after Experimental Stroke
2008
Transcriptional Regulation of the Tissue Factor Gene by Progestins in Human Endometrial Stromal Cells1
1998
Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders
2005 Standout
High-level expression of Egr-1 and Egr-1–inducible genes in mouse and human atherosclerosis
2000
Protecting the myocardium: A role for the β2 adrenergic receptor in the heart
2004 StandoutNobel
The Raf/MEK/ERK signal transduction cascade as a target for chemotherapeutic intervention in leukemia
2002
Clinical Effect of Point Mutations in Myelodysplastic Syndromes
2011 Standout
Angiotensin II-induced Transcriptional Activation of the Cyclin D1 Gene Is Mediated by Egr-1 in CHO-AT1A Cells
2001
Atherosclerosis — An Inflammatory Disease
1999 Standout
Defining roles of specific reactive oxygen species (ROS) in cell biology and physiology
2022 Standout
Increased leukemia-associated gene expression in benzene-exposed workers
2014
Environmental Enrichment Reduces Aβ Levels and Amyloid Deposition in Transgenic Mice
2005 Standout
Configuration of the TP53 Gene as an Independent Prognostic Parameter of Myelodysplastic Syndrome
2003
Genetics of therapy-related myelodysplasia and acute myeloid leukemia
2008
CURCUMIN: THE INDIAN SOLID GOLD
2007 Standout
p53 protein expression independently predicts outcome in patients with lower-risk myelodysplastic syndromes with del(5q)
2014
Stable Interaction between β-Arrestin 2 and Angiotensin Type 1A Receptor Is Required for β-Arrestin 2-mediated Activation of Extracellular Signal-regulated Kinases 1 and 2
2004 StandoutNobel
International prognostic scoring system and TP53 mutations are independent prognostic indicators for patients with myelodysplastic syndrome
2001
Early growth response proteins (EGR) and nuclear factors of activated T cells (NFAT) form heterodimers and regulate proinflammatory cytokine gene expression
2003
BCR/ABL regulates response to DNA damage: the role in resistance to genotoxic treatment and in genomic instability
2002
ROS signalling in the biology of cancer
2017 Standout
Muscle as an Endocrine Organ: Focus on Muscle-Derived Interleukin-6
2008 Standout
Up-regulation of Apoptosis Inhibitory Protein IAP-2 by Hypoxia
2001 StandoutNobel
Oxygen homeostasis
2009 StandoutNobel
Pulmonary expression of early growth response-1: biphasic time course and effect of oxygen concentration
2000
Toll-Like Receptors
2003 Standout
Tissue factor transcription driven by Egr-1 is a critical mechanism of murine pulmonary fibrin deposition in hypoxia
1998
O2-regulated gene expression: transcriptional control of cardiorespiratory physiology by HIF-1
2004 StandoutNobel
Activation of glomerular mitogen-activated protein kinases in angiotensin II-mediated hypertension.
1998 StandoutNobel
Adaptive and Maladaptive Cardiorespiratory Responses to Continuous and Intermittent Hypoxia Mediated by Hypoxia-Inducible Factors 1 and 2
2012 StandoutNobel
After chronic myelogenous leukemia: tyrosine kinase inhibitors in other hematologic malignancies
2004
Egr-1 is Activated in Endothelial Cells Exposed to Fluid Shear Stress and Interacts With a Novel Shear-Stress-Response Element in the PDGF A-Chain Promoter
1997
Metal–organic frameworks: functional luminescent and photonic materials for sensing applications
2017 Standout
Stromal Cell–Derived Factor-1α and CXCR4 Expression in Hemangioblastoma and Clear Cell-Renal Cell Carcinoma: von Hippel-Lindau Loss-of-Function Induces Expression of a Ligand and Its Receptor
2005 StandoutNobel
Diminished molecular response to doxorubicin and loss of cardioprotective effect of dexrazoxane inEgr-1deficient female mice
2001
Lipopolysaccharide activation of the MEK-ERK1/2 pathway in human monocytic cells mediates tissue factor and tumor necrosis factor α expression by inducing Elk-1 phosphorylation and Egr-1 expression
2001
Potential Health Effects Associated with Dermal Exposure to Occupational Chemicals
2014 Standout
An ultrastable porous metal–organic framework luminescent switch towards aromatic compounds
2014
Inhibition of Tissue Factor Gene Activation in Cultured Endothelial Cells by Curcumin
1997
Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes
2015 Standout
Regulation of Mammalian O2Homeostasis by Hypoxia-Inducible Factor 1
1999 StandoutNobel
Bioactive Compounds and Biological Functions of Garlic (Allium sativum L.)
2019 Standout
Vascular Endothelial Cell Growth Factor–Induced Tissue Factor Expression in Endothelial Cells Is Mediated by EGR-1
1999
Key Characteristics of Carcinogens as a Basis for Organizing Data on Mechanisms of Carcinogenesis
2015
Endothelial Cell Dysfunction and the Pathobiology of Atherosclerosis
2016 Standout
The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia
2016 Standout
Redox Signaling by Reactive Electrophiles and Oxidants
2018
Effects of Disturbed Flow on Vascular Endothelium: Pathophysiological Basis and Clinical Perspectives
2011 Standout
Up-regulation of vascular endothelial growth factor receptor Flt-1 after endothelial denudation: role of transcription factor Egr-1
2000
Mechanism of Action and In Vivo Role of Platelet-Derived Growth Factor
1999 Standout
Works of M. T. Smith being referenced
Current understanding of the mechanism of benzene-induced leukemia in humans: implications for risk assessment
2011
Changing p53 mutations with the evolution of chronic myeloid leukaemia from the chronic phase to blast crisis
1995
RAS, FMS and p53 mutations and poor clinical outcome in myelodysplasias: a 10-year follow-up
1998
Transcriptional Regulation of the Tissue Factor Gene in Human Epithelial Cells Is Mediated by Sp1 and EGR-1
1996